Pfizer jab safe for children aged 5-11

News Desk

Pfizer and BioNTech have said clinical trial results showed their coronavirus vaccine was “safe, well tolerated” and produced a “robust” immune response in children aged five to 11, adding that they would seek regulatory approval shortly, Reuters reports.

The vaccine would be administered at a lower dosage than for people aged 12 and over, the companies said in a statement. They said they would submit their data to regulatory bodies in the European Union, the United States and around the world “as soon as possible”.


Previous articlePakistan sees significant decline in Covid deaths
Next articleGovt cant misuse ordinance for NAB chief’s appointment